| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |